Hasil Pencarian - Parag Das

  • Menampilkan 1 - 5 hasil dari 5
Perbaiki Hasil
  1. 1
    High treatment related mortality due to infection remains a major challenge in the management of high-grade B-cell Non-Hodgkin Lymphoma in children in developing countries: Experience from a tertiary cancer center in Eastern India

    High treatment related mortality due to infection remains a major challenge in the management of high-grade B-cell Non-Hodgkin Lymphoma in children in developing countries: Experie... oleh Avijeet Kumar Mishra, Shekhar Krishnan, Arpita Bhattacharyya, K.S. Reghu, Anirban Das, Sheetal Kulkarni Modi, Parag Das, Niharendu Ghara

    Diterbitkan 2022-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    Early experience with blinatumomab in B-cell precursor (BCP) acute lymphoblastic leukaemia (ALL) at the Tata Medical Center (TMC), Kolkata

    Early experience with blinatumomab in B-cell precursor (BCP) acute lymphoblastic leukaemia (ALL) at the Tata Medical Center (TMC), Kolkata oleh Debjani Ghosh, Parthasarathi Bhattacharyya, Sangeeta Choini, Manik Ghost, Samik Samaddar, Parag Das, Nandana Das, Vaskar Saha, Shekhar Krishnan, Niharendu Ghara

    Diterbitkan 2022-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    Drug response profiling identifies sensitive synergistic drug combinations for patients with refractory/relapsed acute lymphoblastic leukemia

    Drug response profiling identifies sensitive synergistic drug combinations for patients with refractory/relapsed acute lymphoblastic leukemia oleh Jasmeet Sidhu, Shruti Banerjee, Arko Bhowal, Parag Das, Manash Pratim Gogoi, Ritam Siddhanta, Kankana Das, Niharendu Ghara, Pritha Paul, Shekhar Krishnan, Vaskar Saha

    Diterbitkan 2022-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    Comparative treatment costs of risk‐stratified therapy for childhood acute lymphoblastic leukemia in India

    Comparative treatment costs of risk‐stratified therapy for childhood acute lymphoblastic leukemia in India oleh Tushar Mungle, Nandana Das, Saikat Pal, Manash Pratim Gogoi, Parag Das, Niharendu Ghara, Debjani Ghosh, Ramandeep Singh Arora, Nickhill Bhakta, Vaskar Saha, Shekhar Krishnan

    Diterbitkan 2023-02-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    Protocol for ICiCLe-ALL-14 (InPOG-ALL-15-01): a prospective, risk stratified, randomised, multicentre, open label, controlled therapeutic trial for newly diagnosed childhood acute lymphoblastic leukaemia in India

    Protocol for ICiCLe-ALL-14 (InPOG-ALL-15-01): a prospective, risk stratified, randomised, multicentre, open label, controlled therapeutic trial for newly diagnosed childhood acute... oleh Nandana Das, Shripad Banavali, Sameer Bakhshi, Amita Trehan, Venkatraman Radhakrishnan, Rachna Seth, Brijesh Arora, Gaurav Narula, Subir Sinha, Prakriti Roy, Manash Pratim Gogoi, Sayan Chatterjee, Bindhu Abraham, Parag Das, Vaskar Saha, Shekhar Krishnan

    Diterbitkan 2022-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: